earnings
IM
NASDAQ · IMVT
Immunovant, Inc.
Healthcare · Biotechnology
$42.60
Down-$0.48 (-1.13%)
Updated Aug 13, 2026, 5:26 PM
SID Score
6.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.35B
- P/E ratio
- -9.28
- Dividend yield
- 0.00%
- 52-week range
- $22.79 – $41.23
- Volume
- 2M
- Avg. volume
- 1.69M
Price performance
IMVT price history
1M range · 21 trading sessions · Daily adjusted prices
IMVT closed at $42.60 after 21 trading sessions, up 6.82% for the selected period.
- Last close
- $42.60
- Period change
- +6.82%
- Period low
- $38.51
- Period high
- $42.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $40.92 | $42.62 | $40.705 | $42.60 | 2M |
| Aug 11, 2026 | $39.66 | $40.93 | $38.985 | $40.93 | 1.14M |
| Aug 10, 2026 | $39.95 | $40.00 | $39.13 | $39.89 | 1.19M |
| Aug 7, 2026 | $39.86 | $40.33 | $38.95 | $39.95 | 906.3K |
| Aug 6, 2026 | $37.98 | $39.85 | $37.98 | $39.74 | 917.99K |
| Aug 5, 2026 | $39.73 | $39.975 | $38.72 | $39.28 | 1.52M |
| Aug 4, 2026 | $39.13 | $39.76 | $38.80 | $39.36 | 990.65K |
| Aug 3, 2026 | $38.28 | $38.87 | $36.78 | $38.51 | 704.17K |
| Jul 31, 2026 | $39.31 | $39.32 | $38.00 | $38.62 | 669.68K |
| Jul 30, 2026 | $38.61 | $39.80 | $38.47 | $39.48 | 668.09K |
| Jul 29, 2026 | $38.98 | $39.41 | $37.75 | $38.61 | 1.62M |
| Jul 28, 2026 | $40.09 | $40.28 | $38.58 | $38.90 | 897.63K |
| Jul 27, 2026 | $39.97 | $40.77 | $39.72 | $40.09 | 930.54K |
| Jul 24, 2026 | $39.80 | $39.87 | $38.70 | $39.41 | 727.08K |
| Jul 23, 2026 | $38.39 | $39.60 | $38.00 | $39.37 | 784.11K |
| Jul 22, 2026 | $39.13 | $39.43 | $38.77 | $39.05 | 767.37K |
| Jul 21, 2026 | $39.76 | $40.248 | $39.33 | $39.53 | 1.25M |
| Jul 20, 2026 | $40.30 | $41.21 | $39.77 | $39.92 | 733.44K |
| Jul 17, 2026 | $38.17 | $40.47 | $38.01 | $40.26 | 882.23K |
| Jul 16, 2026 | $39.50 | $39.87 | $38.475 | $38.96 | 967.31K |
| Jul 15, 2026 | $38.48 | $39.91 | $37.91 | $39.88 | 754.95K |
Latest IMVT news
The latest Smart Investors Daily articles mentioning IMVT.
Stock researchCompany · Financials
Loading stock research…